Increase of tumor necrosis factor-α in the blood induces early activation of matrix metalloproteinase-9 in the brain

Microbiology and Immunology

Volumn 54, Issue 7, 2010, Pages 417-424

  Tsuge, Mitsuru ^a   Yasui, Kozo ^a   Ichiyawa, Takashi ^b   Saito, Yukie ^a   Nagaoka, Yoshiharu ^a   Yashiro, Masato ^a   Yamashita, Nobuko ^a   Morishima, Tsuneo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood brain barrier; Influenza associated encephalopathy; Matrix metalloproteinase 9; Tumor necrosis factor alpha

Indexed keywords

EVANS BLUE; GELATINASE A; GELATINASE B; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN TISSUE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE STORM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME LOCALIZATION; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; VASCULAR ENDOTHELIUM; WILD TYPE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; ENZYME ACTIVATION; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77954530003     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00226.x     Document Type: Article

References (28)

1. Kieseier B.C., Paul R., Koedel U., Seifert T., Clements J.M., Gearing A.J., Pfister H.W., Hartung H.P. (1999) Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122: 1579-87.
2. Baldwin A.C., Kielian T. (2004) Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151: 24-32.
3. Yang G.Y., Gong C., Qin Z., Liu X.H., Lorris Betz A. (1999) Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69: 135-43.
4. Yong V.W., Power C., Forsyth P., Edwards D.R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2: 502-11.
5. Rosenberg G.A. (2002) Matrix metalloproteinases in neuroinflammation. Glia 39: 279-91.
6. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-30.
7. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., Chan P.H. (1999) Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842: 92- 100.
8. Lee S.R., Tsuji K., Lee S.R., Lo E.H. (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24: 671-8.
9. Lee H., Park J.W., Kim S.P., Lo E.H., Lee S.R. (2009) Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol Dis 34: 189-98.
10. Rosenberg G.A., Navratil M. (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48: 921-6.
11. Horstmann S., Su Y., Koziol J., Meyding-Lamadé U., Nagel S., Wagner S. (2006) MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci 251: 82-6.
12. Lorenzl S., Albers D.S., Narr S., Chirichigno J., Beal M.F. (2002) Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp Neurol 178: 13-20.
13. Kiaei M., Kipiani K., Calingasan N.Y., Wille E., Chen J., Heissig B., Rafii S., Lorenzl S., Beal M.F. (2007) Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 205: 74-81.
14. Leib S.L., Leppert D., Clements J., Täuber M.G. (2000) Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 68: 615-20.
15. Leib S.L., Clements J.M., Lindberg R.L., Heimgartner C., Loeffler J.M., Pfister L.A., Täuber M.G., Leppert D. (2001) Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124: 1734-42.
16. Lee K.Y., Kim E.H., Yang W.S., Ryu H., Cho S.N., Lee B.I., Heo J.H. (2004) Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 220: 73-8.
17. Morishima T., Togashi T., Yokota S., Okuno Y., Miyazaki C., Tashiro M., Okabe N.; Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. (2002) Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35: 512-7.
18. Kawada J., Kimura H., Ito Y., Hara S., Iriyama M., Yoshikawa T., Morishima T. (2003) Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 188: 690-8.
19. Ichiyama T., Isumi H., Ozawa H., Matsubara T., Morishima T., Furukawa S. (2003) Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 35: 59-61.
20. Ichiyama T., Morishima T., Isumi H., Matsufuji H., Matsubara T., Furukawa S. (2004) Analysis of cytokine levels and NF-kappa B activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 27: 31-7.
21. Ichiyama T., Morishima T., Kajimoto M., Matsushige T., Matsubara T., Furukawa S. (2007) Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 26: 542-4.
22. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Stetler-Stevenson W.G. (1995) Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 703: 151-5.
23. Abraham C.S., Deli M.A., Joo F., Megyeri P., Torpier G. (1996) Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett 208: 85-8.
24. Sellner J., Leib S.L. (2006) In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis 21: 647-56.
25. Sellner J., Simon F., Meyding-Lamade U., Leib S.L. (2006) Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res 1125: 155-62.
26. Polavarapu R., Gongora M.C., Winkles J.A., Yepes M. (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25: 10094-100.
27. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., Lo E.H. (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21: 7724-32.
28. Copin J.C., Merlani P., Sugawara T., Chan P.H., Gasche Y. (2008) Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats. Exp Neurol 213: 196-201.